Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Amundi

Amundi cut its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 22.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 82,518 shares of the company's stock after selling 23,600 shares during the period. Amundi's holdings in Ryan Specialty were worth $5,044,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of RYAN. Sanctuary Advisors LLC raised its holdings in shares of Ryan Specialty by 1.2% in the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock valued at $1,045,000 after purchasing an additional 188 shares in the last quarter. State of Alaska Department of Revenue boosted its holdings in shares of Ryan Specialty by 1.6% in the 4th quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company's stock valued at $778,000 after buying an additional 190 shares in the last quarter. CIBC Asset Management Inc grew its holdings in shares of Ryan Specialty by 5.6% during the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock worth $236,000 after purchasing an additional 196 shares during the last quarter. Loomis Sayles & Co. L P grew its stake in Ryan Specialty by 26.3% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock worth $91,000 after buying an additional 286 shares during the last quarter. Finally, Exchange Traded Concepts LLC grew its position in shares of Ryan Specialty by 2.6% during the fourth quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company's stock worth $755,000 after acquiring an additional 295 shares during the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Ryan Specialty Trading Up 1.2 %

Shares of NYSE RYAN traded up $0.88 during midday trading on Wednesday, hitting $71.96. The stock had a trading volume of 551,007 shares, compared to its average volume of 971,485. The company has a fifty day moving average price of $67.51 and a 200 day moving average price of $67.86. The company has a market capitalization of $18.85 billion, a price-to-earnings ratio of 104.29, a PEG ratio of 1.19 and a beta of 0.71. Ryan Specialty Holdings, Inc. has a 1-year low of $48.48 and a 1-year high of $75.97. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $663.53 million during the quarter, compared to analysts' expectations of $658.80 million. On average, analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date was Tuesday, March 4th. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is currently 69.57%.

Analysts Set New Price Targets

RYAN has been the topic of several recent research reports. Wells Fargo & Company boosted their price target on Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a research report on Friday, February 21st. Barclays upped their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a research note on Thursday, November 21st. Keefe, Bruyette & Woods dropped their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a research note on Friday, February 21st. Royal Bank of Canada reduced their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research note on Friday, February 21st. Finally, UBS Group raised their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $75.27.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 10,485 shares of the firm's stock in a transaction that occurred on Thursday, January 23rd. The stock was sold at an average price of $65.12, for a total transaction of $682,783.20. Following the completion of the sale, the director now owns 11,109 shares in the company, valued at $723,418.08. This trade represents a 48.56 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold 241,451 shares of company stock valued at $16,012,343 over the last 90 days. 11.10% of the stock is owned by corporate insiders.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.